Position in RPRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$161,316,968
+$41,992,862 QoQ
Shares Held
3,362,872
+8.9% QoQ
Ownership
0.584%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,030,824,133 across 242 Biotechnology names. RPRX ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $161,316,968 | 3,362,872 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $119,324,106 | 3,088,098 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $99,580,127 | 2,822,566 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $97,968,920 | 2,719,093 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $87,502,693 | 2,810,880 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $67,190,329 | 2,633,882 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $73,210,332 | 2,587,852 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $67,518,512 | 2,560,429 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $71,940,576 | 2,368,804 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $66,687,091 | 2,374,051 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $69,115,755 | 2,546,638 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $74,225,725 | 2,414,630 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $81,190,001 | 2,253,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $88,482,750 | 2,238,936 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $91,513,847 | 2,277,597 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $93,887,721 | 2,233,295 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $82,783,765 | 2,124,840 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $73,424,262 | 1,842,516 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $54,030,383 | 1,495,030 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $60,306,002 | 1,471,237 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $61,180,189 | 1,402,572 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $23,702,627 | 473,579 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,107,829 | 26,333 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,221,389 | 66,352 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||